Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment

Cancer Immunology Immunotherapy

Volumn 44, Issue 2, 1997, Pages 77-82

  Belfrage, Hans ^a   Dohlsten, Mikael ^a,b   Hedlund, Gunnar ^a,b   Kalland, Terje ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b Pharmacia & Upjohn AB   (Sweden)

Author keywords

IL 2; staphylococcal enterotoxin A; supantigen

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030915705     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050358     Document Type: Article

References (35)

1. Arnold B, Schönrich G, Hämmerling GJ (1993) Multiple levels of peripheral tolerance. Immunol Today 14:12
2. Belfrage H, Dohlsten M, Hedlund G, Kalland T (1995) Enhanced and prolonged efficacy of superantigen induced CTL activity by IL-2 in vivo. Cancer Immunol Immunother 41:87
3. Belfrage H, Dohlsten M, Hedlund G, Kalland T (1996) Prevention of superantigen induced down-regulation of T cell mediated cytotoxic activity by IL-2 in vivo. (in press)
4. Beverly B, Kang S, Lenardo M, Schwartz R (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4:661
5. Boussiotis VA, Barber DL, Nakarai T, Freeman GJ, Gribben JG, Bernstein GM, D'Andrea AD, Ritz J, Nadler LM (1994) Prevention of T cell anergy by signalling through the γc chain of the IL-2 receptor. Science 266:1039
6. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM (1995) The critical role of CD28 signalling in the prevention of human T-cell anergy. Res Immunol 146:140
7. Cheever MA, Thompson JA, Peace DJ, Greenberg PD (1986) Potential uses of interleukin-2 in cancer therapy. Immunobiology 172:365
8. + T-cell subsets in vivo. Immunol Rev 123:189
9. Dohlsten M, Hedlund G, Segrén S, Lando PA, Herrmann T, Kelly AP, Kalland T (1991) Human major histocompatibility complex class II negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Eur J Immunol 21:1229
10. Dohlsten M, Hedlund G, Åkerblom E, Lando PA, Kalland T (1991) Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proc Natl Acad Sci USA 88:9287
11. β3 transgenic mice. Immunology 79:520
12. Dohlsten M, Sundstedt A, Björklund M, Hedlund G, Kalland T (1993) Superantigen-induced cytokines supress growth of human colon-carcinoma cells. Int J Cancer 54:482
13. Dohlsten M, Abrahamsén L, Björk P, Lando PA, Hedlund G, Forsberg G, Brodin T, Gascoigne NRJ, Förberg C, Lind P, Kalland T (1994) Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell based tumor therapy. Proc Natl Acad Sci USA 91:8945
14. Essery G, Feldmann M, Lamp J (1988) Interleukin-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 64:413
15. Hedlund G, Dohlsten M, Herrmann T, Buell G, Lando PA, Segrén S, Schrimser J, Macdonald HR, Sjögren HO, Kalland T (1991) A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol 47:4082
16. Hedlund G, Dohlsten M, Petersson C, Kalland T (1993) Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells. Cancer Immunol Immunother 36:89
17. Ishii H, Gouchi A and Orita K (1994) The enhancement of cell surface ICAM-1 and HLA-class-I antigens in human gastric cancer cell lines by IFNγ. Acta Med Okayama 48:73
18. Kalland T, Hedlund G, Dohlsten M, Lando PA (1991) Staphylococcal enterotoxin dependent cell-mediated cytotoxicity. Curr Top Microbiol Immunol 174:81
19. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245
20. + cells in staphylococcal enterotoxin B-primed mice. J Exp Med 172:1065
21. Kelly CP, O'Keane JC, Orellana J, Schroy PC, Yang S, La Mont JT, Brady HR (1992) Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am J Physiol 263:864
22. Lando PA, Dohlsten M, Hedlund G, Åkerblom E, Kalland T (1993) T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens. Cancer Immunol Immunother 36:223
23. Lotze MT, Matory YL, Ettinhausen SE, Rayner AA, Sharrow SO, Scipp CAY, Custer MC, Rosenberg SA (1985) In vivo administration of purified human interleukin-2. II. Half life, immunological effects and expansion of peripheral lymphoid cells in vivo with recombinant IL2. J Immunol 135:2865
24. + peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur J Immunol 21:1963
25. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer stimulatory factor (NKSF/IL-12) induces Th1-type specific immune response and inhibits the development of IL-4 producing Th cells. J Exp Med 177:1199
26. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248:705
27. McCormack JE, Callahan JE, Kappler J, Marrack PC (1993) Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150:3785
28. Miethke T, Wahl C, Gaus H, Heeg K, Wagner H (1994) Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosupression: dose-response relationship. Eur J Immunol 24:1893
29. Musso T, Espinoza-Delgado I, Pulkki K, Gusella Gl, Longo DL, Varesio L (1992) IL-2 induces IL-6 production in human monocytes. J Immunol 148:795
30. Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T (1988) IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 141:1543
31. + T cells by staphylococcal enterotoxin B J Exp Med 172:1091
32. Renauld JC, Vink A, Van Snick J (1989) IL1 and IL6 in CTL induction-accessory signals in murine cytolytic T cell responses: dual requirement for IL1 and IL6. J Immunol 143:1894
33. Sundstedt A, Dohlsten M, Hedlund G, Höidén I, Björklund M, Kalland T (1994) Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology 82:117
34. + T cells. J Immunol 154:6307
35. Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH (1988) B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 140:508